Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Net Income - Minority (2016 - 2021)

Historic Net Income - Minority for Cumberland Pharmaceuticals (CPIX) over the last 12 years, with Q2 2021 value amounting to $144352.0.

  • Cumberland Pharmaceuticals' Net Income - Minority rose 10782.33% to $144352.0 in Q2 2021 from the same period last year, while for Jun 2021 it was $144352.0, marking a year-over-year increase of 10782.33%. This contributed to the annual value of $117116.0 for FY2020, which is 21131.31% up from last year.
  • As of Q2 2021, Cumberland Pharmaceuticals' Net Income - Minority stood at $144352.0, which was up 10782.33% from $139283.0 recorded in Q1 2021.
  • Cumberland Pharmaceuticals' 5-year Net Income - Minority high stood at $372306.0 for Q2 2019, and its period low was $25980.0 during Q3 2019.
  • Its 5-year average for Net Income - Minority is $163569.9, with a median of $154798.5 in 2017.
  • Its Net Income - Minority has fluctuated over the past 5 years, first tumbled by 8990.09% in 2019, then skyrocketed by 22881.45% in 2020.
  • Cumberland Pharmaceuticals' Net Income - Minority (Quarter) stood at $198562.0 in 2017, then soared by 38.13% to $274266.0 in 2018, then plummeted by 86.28% to $37620.0 in 2019, then skyrocketed by 211.31% to $117116.0 in 2020, then increased by 23.26% to $144352.0 in 2021.
  • Its Net Income - Minority was $144352.0 in Q2 2021, compared to $139283.0 in Q1 2021 and $117116.0 in Q4 2020.